| Literature DB >> 33566198 |
Sanaz Jafarpour Azami1,2, Hanieh Mohammad Rahimi1, Hamed Mirjalali3, Mohammad Reza Zali4.
Abstract
Toxoplasma gondii is a worldwide protozoan parasite that infects almost all warm-blooded animals. Although human toxoplasmosis is mostly latent, pregnant women and immunocompromised patients need effective treatment. There are drugs of choice for treatment of toxoplasmosis; however, due to their side effects and/or their disease stage-specificity, prescription of them is limited. During recent years, nanomedicine has been employed to overcome limitations of conventional drugs. Here, we provided a state-of-the-art review of experimental toxoplasmosis treatment using nanotechnology.Entities:
Keywords: Acute toxoplasmosis; Chronic toxoplasmosis; Conventional therapy; Nanomedicine; Toxoplasma gondii; Treatment
Year: 2021 PMID: 33566198 DOI: 10.1007/s11274-021-03000-x
Source DB: PubMed Journal: World J Microbiol Biotechnol ISSN: 0959-3993 Impact factor: 3.312